Towa Pharmaceutical Co., Ltd. · TSE:4553
Towa Pharmaceutical — Q2 FY2010 Earnings Presentation
17 slides from Towa Pharmaceutical's earnings presentation, Nov 9, 2009
Slide 1: Second Quarter Results Presentation
2009 2 2009 11 9 ( 4553)
Slide 2: Results summary for September 2009 period
2009 9 ( %) 09/9 08/9 +1,928 19,068 17,140 (+11.3) +1,515 9,778 51.3 8,263 48.2 (+18.3) +404 6,030 31.6 5,625 32.8 (+7.2) +1,110 3,748 19.7 2,637 15.4 (+42.1) +399 3,180 16.7 2,780 16.2 (+14.3) +242 2 1,910 10.0 1,667 9.7 (+14.6) -1-
Slide 3: Sales change analysis year over year
379 09 379 +386 08 04 +2,307 03 05 19,068 +229 +48 +1,024 02 +215 +244 +80 07 +81 06 17,140 08 08/9 09/9 -2-
Slide 4: z 09 z 08 OD
09/9 82 22 21 15 17 6 8 15 4 190 08/9 86 21 19 13 16 6 6 5 171 07/9 87 20 17 9 13 4 2 151 50 100 150 200 02 03 04 05 06 07 08 09 z 09 5 5 OD z 08 z 02 07 z -3-
Slide 5: ( ) 07/9 08/9 09/9 CR -4-
( ) 15 07/9 08/9 09/9 10 5 0 CR -4-
Slide 6: Cost breakdown ratios
( ) 09 26.1% 66.5% 7.4% 08 26.4% 66.8% 6.8% 08 26.3% 66.5% 7.2% 07 25.1% 69.2% 5.7% 07 26.8% 68.0% 5.2% 0 100 200 -5-
Slide 7: Sales composition
( ) 09 52.5% 33.6% 11.2% 2.7% 08 56.1% 30.4% 10.3% 3.2% 08 57.7% 28.6% 10.2% 3.5% 07 60.9% 26.0% 10.1% 3.0% 07 61.8% 24.8% 10.3% 3.1% -6-
Slide 8: Operating profit analysis
( ) 09/9 z 2,885 88 (2,797) z 1,097 53 (1,044) 413 ▲48 (461) z 1,633 311 (1,322) 6,030 404 z +245 (5,625) -7-
Slide 9: Income statement
( ) 09/9 08/9 19,068 17,140 9,778 8,263 6,030 5,625 3,748 2,637 104 288 0 142 z 445 673 145 197 114 445 ― 09/3 97.23 /$ 3,180 2,780 09/9 89.21 /$ 1 330 0 231 23 309 20 201 3,158 2,801 2 1,910 1,667 -8-
Slide 10: Balance sheet
( ) 09/9 09/3 8,184 2,912 +5,272 14,041 13,902 +139 323 512 ▲189 9,583 9,435 +148 329 ▲329 -283 -40 ▲243 1,331 1,360 ▲28 33,180 28,410 +4,770 20,241 19,828 +413 53,422 48,238 +5,184 4,150 4,330 ▲180 4,701 4,912 ▲211 4,000 8,851 9,242 ▲391 4,962 950 +4,012 13,813 10,193 +3,621 39,608 38,045 +1,563 53
Slide 11: Full-year forecast
( %) 10/3 ( ) 09/3 39,300 +9.3 35,966 7,600 19.3 +18.6 6,408 17.8 7,100 18.1 +6.2 6,682 18.6 4,260 10.8 +12.8 3,777 10.5 -10-
Slide 12: Forecast versus previous forecast
( ) 10/3 10/3 39,300 39,000 +300 20,000 19,100 +900 49.0% 50.9% 12,400 11,700 +700 +334 7,600 7,400 +200 +245 7,100 7,500 -400 2 4,260 4,500 -240 -11-
Slide 13: Five-year trend
30 25 23 22 19 18 20 17 10 0 06/3 07/3 08/3 09/3 10/3 -12-
Slide 14: Five-year trend
90 60 54 25 30 24 1 13 13 26 22 26 0 06/3 07/3 08/3 09/3 10/3 -13-
Slide 15: New products
09 11 08 100mg 459 100mg/ 335 75mg/ 10% 234 100mg/50mg 0.5g/0.25g 117 25mg/mL 482 18 30 -14-
Slide 16: Schedule
z ¾ 2010 3 2011 8 ¾ 2012 3 ¾ 10/3 11/3 12/3 13/3 14/3 15/3 16/3 54 70 80 10 ― ― ― ― ― 17 37 27 20 15 -15-
Slide 17: Contact
TEL 06-6900-9101 FAX 06-6900-0634 -16-
Towa Pharmaceutical — Q2 FY2010 Earnings Presentation on 6ix